Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.

(BHVN)
Delayed Nyse  -  04:00 2022-11-29 pm EST
15.40 USD   +6.87%
11/10William Blair Initiates Biohaven Pharmaceutical Holding Company With Outperform Rating
MT
11/09BIOHAVEN LTD. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
11/09Biohaven's Q3 Adjusted Loss Widens
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Days
:
Hours
:
Minutes
:
Seconds

Biohaven Pharmaceutical's Acquisition by Pfizer Likely to Close Oct. 3

09/27/2022 | 05:37pm EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. 6.87% 15.4 Delayed Quote.-89.54%
PFIZER, INC. -0.16% 49.49 Delayed Quote.-16.05%
All news about BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
11/10William Blair Initiates Biohaven Pharmaceutical Holding Company With Outperform Rating
MT
11/09BIOHAVEN LTD. Management's Discussion and Analysis of Financial Condition and Results ..
AQ
11/09Biohaven's Q3 Adjusted Loss Widens
MT
11/09Earnings Flash (BHVN) BIOHAVEN Reports Q3 Loss $-1.25
MT
11/01Insider Buy: Biohaven
MT
10/31Insider Buy: Biohaven
MT
10/27Insider Buy: Biohaven
MT
10/27Insider Buy: Biohaven
MT
10/27Insider Buy: Biohaven
MT
10/27Insider Buy: Biohaven
MT
More news
Analyst Recommendations on BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
More recommendations
Financials (USD)
Sales 2022 - - -
Net income 2022 -211 M - -
Net Debt 2022 - - -
P/E ratio 2022 -49,0x
Yield 2022 -
Capitalization 541 M 541 M -
Capi. / Sales 2022 -
Capi. / Sales 2023 -
Nbr of Employees 928
Free-Float 90,1%
Chart BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Duration : Period :
Biohaven Pharmaceutical Holding Company Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers and Directors
Paloma Fernßndez-Montes Moraleda President & Director
David Saunders Finance Director
Loren Aguiar Vice President-Research & Development
Melissa Beiner Director-Research & Development
Jon Blaskovich Director-Information Technology
Sector and Competitors
1st jan.Capi. (M$)
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.-89.54%541
MODERNA, INC.-30.95%67 378
IQVIA HOLDINGS INC.-23.99%39 832
LONZA GROUP AG-34.32%39 180
ALNYLAM PHARMACEUTICALS, INC.23.36%25 738
SEAGEN INC.-21.59%22 506